MCHM Macrochem (MM)

MacroChem CEO to Present at BIO 2004 Business Forum LEXINGTON, Mass., June 7 /PRNewswire-FirstCall/ -- MacroChem Corporation (NASDAQ:MCHM), a specialty pharmaceutical company, announced today that its president and CEO, Robert J. DeLuccia, will present at the BIO Business Forum tomorrow in San Francisco. The BIO Business Forum is a major component of the BIO 2004 Annual International Convention, which runs June 6-9 at San Francisco's Moscone Center. It is the world's largest biotechnology gathering, with more than 17,000 preregistered attendees. The Business Forum will span three days, during which attendees will listen to the Business Forum presentations by companies. Mr. DeLuccia will discuss the company's two products currently in clinical trials -- Opterone(TM), a topical treatment for male testosterone deficiency, and EcoNail(TM), an antifungal nail lacquer for treating a common nail infection, onychomycosis. The two products are based on the company's enhancer SEPA(TM), which improves skin absorption of a variety of pharmaceutical ingredients, and enhances release of antifungal drugs from nail lacquer matrix. With the exception of historical information contained in this press release, the matters described herein are forward-looking statements and are subject to various risk factors that could cause actual results to differ materially from those expressed in the forward-looking statements. The relevant risk factors are set forth in MacroChem's annual report on Form 10-K as filed with the SEC and include, without limitation, risks regarding product development, clinical trials, dependence on third parties for development and licensing arrangements, and risks involving regulatory approval of products, and patents and licenses. Visit our web site at: http://www.macrochem.com/ Contact: Bernard Patriacca - VP/CFO (781) 862-4003 DATASOURCE: MacroChem Corporation CONTACT: Bernard Patriacca, VP/CFO of MacroChem, +1-781-862-4003 Web site: http://www.macrochem.com/

Copyright